by Ming Mui | Jul 10, 2025 | Market News, Medical Use, Pharmaceutical, Stock Market
Shares of ProKidney Corp (NASDAQ: PROK) soared more than 25% in Thursday afternoon trading after the company reported encouraging topline results from its Phase 2 REGEN-007 trial evaluating rilparencel in patients with chronic kidney disease (CKD) and diabetes. The...
by Ming Mui | Jan 24, 2025 | Healthcare, Investing News, Medical Use, Stock Market
Novo Nordisk (NVO) experienced a significant surge in pre-market trading on Friday, with its stock climbing 12% following the announcement of promising results from an early-stage clinical trial for its new obesity treatment, amycretin. The Danish pharmaceutical giant...
